151 related articles for article (PubMed ID: 6149279)
1. Passive inhalation of cannabis smoke.
Law B; Mason PA; Moffat AC; King LJ; Marks V
J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279
[TBL] [Abstract][Full Text] [Related]
2. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
3. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
[TBL] [Abstract][Full Text] [Related]
5. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
Cone EJ; Johnson RE; Darwin WD; Yousefnejad D; Mell LD; Paul BD; Mitchell J
J Anal Toxicol; 1987; 11(3):89-96. PubMed ID: 3037193
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
[TBL] [Abstract][Full Text] [Related]
7. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
[TBL] [Abstract][Full Text] [Related]
8. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke.
Mason AP; Perez-Reyes M; McBay AJ; Foltz RL
J Anal Toxicol; 1983; 7(4):172-4. PubMed ID: 6314043
[TBL] [Abstract][Full Text] [Related]
10. Monitoring urine for inhaled cannabinoids.
Moffat AC
Arch Toxicol Suppl; 1986; 9():103-10. PubMed ID: 3028322
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.
Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O
J Pharm Pharm Sci; 2016; 19(3):411-422. PubMed ID: 27806250
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
13. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Cone EJ; Johnson RE
Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628
[TBL] [Abstract][Full Text] [Related]
14. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
McBurney LJ; Bobbie BA; Sepp LA
J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
16. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
17. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.
Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924
[No Abstract] [Full Text] [Related]
19. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
[TBL] [Abstract][Full Text] [Related]
20. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.
Cone EJ; Bigelow GE; Herrmann ES; Mitchell JM; LoDico C; Flegel R; Vandrey R
J Anal Toxicol; 2015 Sep; 39(7):497-509. PubMed ID: 26139312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]